Pancreatic cancer is one of the deadliest forms of cancer, largely because it’s so difficult to catch early. By the time it’s ...

Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer in Blood ...

Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.

Furthermore, existing biomarkers, such as CA19-9, are not reliable on their own to detect early-stage pancreatic cancer. Goel, Xu, and colleagues explored the potential of an exosome-based liquid ...

A new blood test could diagnose pancreatic cancer ... As with most types of cancer, once the tumor has spread, it becomes much harder to successfully treat. “Liquid biopsy” tests which use ...

"Unlike traditional imaging, which requires specific equipment and expertise, liquid biopsy could become a widely accessible ...

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ... endoscopic ultrasound and other liquid biopsy tests that require ...

(MENAFN- EIN Presswire) Major Pharmaceutical companies are working to advance the pipeline space and unlock the future growth potential of the pancreatic cancer treatment landscape. LAS VEGAS , NV ...